These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

65 related items for PubMed ID: 7686174

  • 1. Blockade of AMPA receptors reduces brain edema following opening of the blood-brain barrier.
    Westergren I, Johansson BB.
    J Cereb Blood Flow Metab; 1993 Jul; 13(4):603-8. PubMed ID: 7686174
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological reduction of brain edema induced by intracarotid infusion of protamine sulphate: a comparison between a free radical scavenger and an AMPA receptor antagonist.
    Johansson BB, Westergren I.
    Acta Neurochir Suppl (Wien); 1994 Jul; 60():128-31. PubMed ID: 7976524
    [Abstract] [Full Text] [Related]

  • 3. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia.
    Nellgård B, Wieloch T.
    J Cereb Blood Flow Metab; 1992 Jan; 12(1):2-11. PubMed ID: 1345757
    [Abstract] [Full Text] [Related]

  • 4. Delayed antagonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma.
    Wrathall JR, Teng YD, Marriott R.
    Exp Neurol; 1997 Jun; 145(2 Pt 1):565-73. PubMed ID: 9217092
    [Abstract] [Full Text] [Related]

  • 5. Calcium movements in traumatic brain injury: the role of glutamate receptor-operated ion channels.
    Nilsson P, Laursen H, Hillered L, Hansen AJ.
    J Cereb Blood Flow Metab; 1996 Mar; 16(2):262-70. PubMed ID: 8594058
    [Abstract] [Full Text] [Related]

  • 6. Role of glutamate receptors in the development and maintenance of bladder overactivity after cerebral infarction in the rat.
    Yokoyama O, Mizuno H, Komatsu K, Akino H, Tanase K, Namiki M.
    J Urol; 2004 Apr; 171(4):1709-14. PubMed ID: 15017271
    [Abstract] [Full Text] [Related]

  • 7. Systemic excitatory amino acid receptor antagonists of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor and of the N-methyl-D-aspartate (NMDA) receptor relieve mechanical hypersensitivity after transient spinal cord ischemia in rats.
    Xu XJ, Hao JX, Seiger A, Wiesenfeld-Hallin Z.
    J Pharmacol Exp Ther; 1993 Oct; 267(1):140-4. PubMed ID: 8229741
    [Abstract] [Full Text] [Related]

  • 8. Effects of the AMPA receptor antagonist NBQX on outcome of newborn pigs after asphyxic cardiac arrest.
    Brambrink AM, Martin LJ, Hanley DF, Becker KJ, Koehler RC, Traystman RJ.
    J Cereb Blood Flow Metab; 1999 Aug; 19(8):927-38. PubMed ID: 10458600
    [Abstract] [Full Text] [Related]

  • 9. Effect of magnesium sulfate administration on blood-brain barrier in a rat model of intraperitoneal sepsis: a randomized controlled experimental study.
    Esen F, Erdem T, Aktan D, Orhan M, Kaya M, Eraksoy H, Cakar N, Telci L.
    Crit Care; 2005 Feb; 9(1):R18-23. PubMed ID: 15693962
    [Abstract] [Full Text] [Related]

  • 10. Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction.
    Xue D, Huang ZG, Barnes K, Lesiuk HJ, Smith KE, Buchan AM.
    J Cereb Blood Flow Metab; 1994 Mar; 14(2):251-61. PubMed ID: 7509339
    [Abstract] [Full Text] [Related]

  • 11. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
    Potschka H, Löscher W, Wlaź P, Behl B, Hofmann HP, Treiber HJ, Szabo L.
    Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
    [Abstract] [Full Text] [Related]

  • 12. Effects of the AMPA-receptor antagonist, NBQX, on neuron loss in dentate hilus of the hippocampal formation after 8, 10, or 12 min of cerebral ischemia in the rat.
    Hu P, Diemer NH, Bruhn T, Johansen FF.
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):147-52. PubMed ID: 9040493
    [Abstract] [Full Text] [Related]

  • 13. The effects of magnesium sulfate on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.
    Kaya M, Gulturk S, Elmas I, Kalayci R, Arican N, Kocyildiz ZC, Kucuk M, Yorulmaz H, Sivas A.
    Life Sci; 2004 Nov 26; 76(2):201-12. PubMed ID: 15519365
    [Abstract] [Full Text] [Related]

  • 14. Influence of nanoparticles on blood-brain barrier permeability and brain edema formation in rats.
    Sharma HS, Hussain S, Schlager J, Ali SF, Sharma A.
    Acta Neurochir Suppl; 2010 Nov 26; 106():359-64. PubMed ID: 19812977
    [Abstract] [Full Text] [Related]

  • 15. 7-Chloro-3-methyl-3-4-dihydro-2H-1,2,4 benzothiadiazine S,S-dioxide (IDRA 21): a benzothiadiazine derivative that enhances cognition by attenuating DL-alpha-amino-2,3-dihydro-5-methyl-3-oxo-4-isoxazolepropanoic acid (AMPA) receptor desensitization.
    Zivkovic I, Thompson DM, Bertolino M, Uzunov D, DiBella M, Costa E, Guidotti A.
    J Pharmacol Exp Ther; 1995 Jan 26; 272(1):300-9. PubMed ID: 7815345
    [Abstract] [Full Text] [Related]

  • 16. NBQX, a competitive non-NMDA receptor antagonist, reduces degeneration due to focal spinal cord ischemia.
    von Euler M, Seiger A, Holmberg L, Sundström E.
    Exp Neurol; 1994 Sep 26; 129(1):163-8. PubMed ID: 7925838
    [Abstract] [Full Text] [Related]

  • 17. Motor performance, histologic damage, and calcium influx in rats treated with NBQX after focal ischemia.
    DeGraba TJ, Ostrow P, Hanson S, Grotta JC.
    J Cereb Blood Flow Metab; 1994 Mar 26; 14(2):262-8. PubMed ID: 8113322
    [Abstract] [Full Text] [Related]

  • 18. Role of NMDA and AMPA glutamate receptors in the induction and the expression of dopamine-mediated sensitization in 6-hydroxydopamine-lesioned rats.
    Pollack AE, St Martin JL, MacPherson AT.
    Synapse; 2005 Apr 26; 56(1):45-53. PubMed ID: 15700284
    [Abstract] [Full Text] [Related]

  • 19. Effect of magnesium, MK-801 and combination of magnesium and MK-801 on blood-brain barrier permeability and brain edema after experimental traumatic diffuse brain injury.
    Imer M, Omay B, Uzunkol A, Erdem T, Sabanci PA, Karasu A, Albayrak SB, Sencer A, Hepgul K, Kaya M.
    Neurol Res; 2009 Nov 26; 31(9):977-81. PubMed ID: 19215660
    [Abstract] [Full Text] [Related]

  • 20. NBQX, an AMPA antagonist, reduces glutamate-mediated brain edema.
    Westergren I, Johansson BB.
    Brain Res; 1992 Feb 28; 573(2):324-6. PubMed ID: 1354550
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.